Pioneering the Future of Precision Therapeutics
Harnessing biology, innovation, and translational science to improve patient outcomes.
Technology Platforms
Advancing vaccines, RNA medicines, cell and gene therapies, and precision healthcare technologies.
AI & Bioinformatics
Applying artificial intelligence and computational biology to uncover novel targets, decode immune responses, and accelerate therapeutic development.
Biomanufacturing Excellence
Establishing Biofoundry - scalable facilities and resilient biomanufacturing ecosystems to enable rapid, cost-effective production of next-generation vaccines and personalized medicines.
Mission
To integrate biological engineering with digital analytics, driving our innovation pipeline through three core pillars:
Next Generation Vaccines
Designing next-generation vaccines that deliver robust, safe, and long-lasting immune protection.
Immuno-Oncology
Harnessing the immune system to recognize and eliminate cancer with precision and durability.
Dr. Sanjay Singh
Founder & CEO
Dr. Sanjay Singh is a distinguished biopharmaceutical innovator and entrepreneur with deep expertise in translational biotechnology, advanced therapeutic platforms, and precision immunotherapy. As the Founder and CEO of Immunoscript Life Sciences Pvt Ltd, he is leading the development of next-generation therapeutic technologies, including advanced cell and gene therapies, engineered immunotherapies, and personalized cancer treatments designed to improve accessibility, scalability, and clinical outcomes.
Dr. Singh earned his Ph.D. in Biochemistry from the Central Drug Research Institute and previously worked at the National Institutes of Health, where he contributed to vaccine development and translational immunology research. He has authored numerous scientific publications, holds multiple patents in biotechnology and vaccine development, and has received several national recognitions for innovation and biopharmaceutical product development.
Dr. Kavita Singh
Co-founder
Dr. Kavita Singh is a physician and public health leader with expertise in microbiology, epidemiology, translational research, and healthcare innovation. With over 25 years of experience spanning the non-profit sector, national scientific programs, and the biopharmaceutical industry, she has contributed extensively to advancing public health research, product development, and scientific capacity building.
